For: | Xu DZ, Zhan YQ, Sun XW, Cao SM, Geng QR. Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol 2004; 10(18): 2727-2730 [PMID: 15309728 DOI: 10.3748/wjg.v10.i18.2727] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v10/i18/2727.htm |
Number | Citing Articles |
1 |
Paul H. Sugarbaker. Optimization of Patient Selection for Surgical Approach to Peritoneal Metastases from Gastrointestinal Cancer Using Cytoreductive Surgery and Perioperative Chemotherapy. Current Colorectal Cancer Reports 2014; 10(3): 272 doi: 10.1007/s11888-014-0226-5
|
2 |
Mei Li M. Kwong, Chukwuemeka Ihemelandu, Paul H. Sugarbaker. Surgery for Gastric Cancer. 2019; : 277 doi: 10.1007/978-3-662-45583-8_24
|
3 |
Deng-Hai Mi, Zheng Li, Ke-Hu Yang, Nong Cao, Anne Lethaby, Jin-Hui Tian, Nancy Santesso, Bin Ma, Yao-Long Chen, Ya-Li Liu. Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: A systematic review and meta-analysis of randomised controlled trials. International Journal of Hyperthermia 2013; 29(2): 156 doi: 10.3109/02656736.2013.768359
|
4 |
P. H. Sugarbaker. Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy. International Journal of Hyperthermia 2007; 23(5): 431 doi: 10.1080/02656730701455318
|
5 |
Ramakrishnan Ayloor Seshadri, Olivier Glehen. The Role of Hyperthermic Intraperitoneal Chemotherapy in Gastric Cancer. Indian Journal of Surgical Oncology 2016; 7(2): 198 doi: 10.1007/s13193-016-0502-8
|
6 |
Dimitrios H Roukos, Angelos M Kappas. Perspectives in the treatment of gastric cancer. Nature Clinical Practice Oncology 2005; 2(2): 98 doi: 10.1038/ncponc0099
|
7 |
Elie Chouillard, Toufic Ata, Bernard De Jonghe, Léon Maggiori, Nada Helmy, Yvan Coscas, Hervé Outin. Staged laparoscopic adjuvant intraperitoneal chemohyperthermia after complete resection for locally advanced colorectal or gastric cancer: a preliminary experience. Surgical Endoscopy 2009; 23(2): 363 doi: 10.1007/s00464-008-9946-4
|
8 |
Javier Lacueva, Javier Gallego, Juan Antonio Díaz-González. Updating controversies on the multidisciplinary management of gastric cancer. Clinical and Translational Oncology 2010; 12(10): 677 doi: 10.1007/s12094-010-0577-6
|
9 |
Roman Yarema, Jerzy Mielko, Taras Fetsych, Myron Ohorchak, Magdalena Skorzewska, Karol Rawicz‐Pruszyński, Artem Mashukov, Viatcheslav Maksimovsky, Tomasz Jastrzębski, Wojciech Polkowski, Petro Gyrya, Yuriy Kovalchuk, Victor Safiyan, Ivan Karelin, Viatcheslav Kopetskiy, Olena Kolesnik, Yuriy Kondratskiy, Marius Paskonis. Hyperthermic intraperitoneal chemotherapy (HIPEC) in combined treatment of locally advanced and intraperitonealy disseminated gastric cancer: A retrospective cooperative Central‐Eastern European study. Cancer Medicine 2019; 8(6): 2877 doi: 10.1002/cam4.2204
|
10 |
Sheng-liu Xue, Mei-long Hu. Catheter-related complications in postoperative intraperitoneal chemotherapy for gastric cancer. Chinese Journal of Cancer Research 2007; 19(3): 222 doi: 10.1007/s11670-007-0222-2
|
11 |
Paul H. Sugarbaker. Building on a consensus. Journal of Surgical Oncology 2008; 98(4): 215 doi: 10.1002/jso.21078
|
12 |
Alisa N. Blumenthaler, Casey J. Allen, Naruhiko Ikoma, Mariela Blum, Prajnan Das, Bruce D. Minsky, Paul F. Mansfield, Jaffer A. Ajani, Brian D. Badgwell. Laparoscopic HIPEC for Low-Volume Peritoneal Metastasis in Gastric and Gastroesophageal Adenocarcinoma. Annals of Surgical Oncology 2020; 27(13): 5047 doi: 10.1245/s10434-020-08968-8
|
13 |
N. A. Alkhamesi, P. F. Ridgway, A. Ramwell, P. W. McCullough, D. H. Peck, A. W. Darzi. Peritoneal nebulizer: a novel technique for delivering intraperitoneal therapeutics in laparoscopic surgery to prevent locoregional recurrence. Surgical Endoscopy 2005; 19(8): 1142 doi: 10.1007/s00464-004-2214-3
|
14 |
Paul H. Sugarbaker. Advances in Peritoneal Surface Oncology. 2007; : 83 doi: 10.1007/978-3-540-30760-0_7
|
15 |
Kun Yang, Xin-Zu Chen, Bo Zhang, Zhi-Xin Chen, Jia-Ping Chen, Jian-Kun Hu. Intraperitoneal chemotherapy for gastric carcinoma. Cochrane Database of Systematic Reviews 2009; 2022(8) doi: 10.1002/14651858.CD008157
|
16 |
Roman Romanovych Yarema, Myron A. Ohorchak, Gennadyi P. Zubarev, Yuriy P. Mylyan, Yuriy Y. Oliynyk, Mykola G. Zubarev, Petro I. Gyrya, Yuriy J. Kovalchuk, Victor I. Safiyan, Taras G. Fetsych. Hyperthermic intraperitoneal chemoperfusion in combined treatment of locally advanced and disseminated gastric cancer: Results of a single-centre retrospective study. International Journal of Hyperthermia 2014; 30(3): 159 doi: 10.3109/02656736.2014.893451
|
17 |
Biao Fan, Zhaode Bu, Ji Zhang, Xianglong Zong, Xin Ji, Tao Fu, Ziyu Jia, Yinan Zhang, Xiaojiang Wu. Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-07925-2
|
18 |
Karol Polom, Luigi Marano, Giandomenico Roviello, Roberto Petrioli, Riccardo Piagnerelli, Lorenzo de Franco, Daniele Marrelli, Franco Roviello. Evolution and emerging future of cytoreducxtive surgery and hyperthermic intraperitoneal chemoperfusion in gastric cancer: From treating the incurable to preventing recurrence. International Journal of Hyperthermia 2016; 32(2): 173 doi: 10.3109/02656736.2015.1111432
|
19 |
Adam C. Fields, Pamela W. Lu, George Z. Li, Vanessa Welten, Joshua S. Jolissaint, Benjamin M. Vierra, Lily V Saadat, Abby C. Larson, Rachel B. Atkinson, Nelya Melnitchouk. Current practices and future steps for hyperthermic intraperitoneal chemotherapy. Current Problems in Surgery 2020; 57(3): 100727 doi: 10.1016/j.cpsurg.2019.100727
|
20 |
Steven C. Cunningham, Richard D. Schulick. Palliative management of gastric cancer. Surgical Oncology 2007; 16(4): 267 doi: 10.1016/j.suronc.2007.08.004
|
21 |
Satoshi Murata, Hiroshi Yamamoto, Tomoharu Shimizu, Hiroyuki Naitoh, Tsuyoshi Yamaguchi, Sachiko Kaida, Katsushi Takebayashi, Toru Miyake, Tohru Tani, Masaji Tani. 5‐fluorouracil combined with cisplatin and mitomycin C as an optimized regimen for hyperthermic intraperitoneal chemotherapy in gastric cancer. Journal of Surgical Oncology 2018; 117(4): 671 doi: 10.1002/jso.24906
|
22 |
Da-zhi Xu, Qi-rong Geng, Ying Tian, Mu-yan Cai, Xin-juan Fang, You-qing Zhan, Zhi-wei Zhou, Wei Li, Ying-bo Chen, Xiao-wei Sun, Yuan-xiang Guan, Yuan-fang Li, Tong-yu Lin. Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer. BMC Cancer 2010; 10(1) doi: 10.1186/1471-2407-10-536
|
23 |
G Matharu, O Tucker, D Alderson. Systematic review of intraperitoneal chemotherapy for gastric cancer. British Journal of Surgery 2011; 98(9): 1225 doi: 10.1002/bjs.7586
|
24 |
Carlo Riccardo Rossi, Alessandro Comandone, Andrea Veltri. New Technologies in Surgical Oncology. 2010; : 113 doi: 10.1007/978-88-470-1475-6_11
|
25 |
Florian Bösch, Jens Werner. Palliative Viszeralchirurgie. 2019; : 233 doi: 10.1007/978-3-662-57362-4_18
|
26 |
Antonio Sommariva, Pierluigi Pilati, Carlo Riccardo Rossi. Cyto-reductive Surgery combined with Hyperthermic Intra-Peritoneal Chemotherapy for Peritoneal Surface Malignancies: Current treatment and results. Cancer Treatment Reviews 2012; 38(4): 258 doi: 10.1016/j.ctrv.2011.07.001
|
27 |
T D Yan, Y Yonemura, D L Morris. Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosis (Br J Surg 2006; 93: 1530–1535). British Journal of Surgery 2007; 94(5): 642 doi: 10.1002/bjs.5867
|
28 |
Shuja Ahmed, John H. Stewart, Perry Shen, Konstantinos I. Votanopoulos, Edward A. Levine. Outcomes with cytoreductive surgery and HIPEC for peritoneal metastasis. Journal of Surgical Oncology 2014; 110(5): 575 doi: 10.1002/jso.23749
|
29 |
Paul H. Sugarbaker. Peritoneal Metastases from Gastrointestinal Cancer. Current Oncology Reports 2018; 20(8) doi: 10.1007/s11912-018-0703-0
|
30 |
C. R. Rossi, A. Comandone, A. Veltri. Nuove tecnologie chirurgiche in oncologia. 2011; : 121 doi: 10.1007/978-88-470-2385-7_11
|
31 |
Ulysses Ribeiro, Fernando Simionato Perrotta. Diffuse Gastric Cancer. 2018; : 49 doi: 10.1007/978-3-319-95234-5_6
|
32 |
Aruna Prabhu, Deepti Mishra, Andreas Brandl, Yutaka Yonemura. Gastric Cancer With Peritoneal Metastasis—A Comprehensive Review of Current Intraperitoneal Treatment Modalities. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.864647
|
33 |
Paul H. Sugarbaker. Surgical responsibilities in the management of peritoneal carcinomatosis. Journal of Surgical Oncology 2010; 101(8): 713 doi: 10.1002/jso.21484
|
34 |
Sheng Yang, Rui Feng, Zhang-Chi Pan, Tao Jiang, Qian Xu, Qiang Chen. A Comparison of Intravenous plus Intraperitoneal Chemotherapy with Intravenous Chemotherapy Alone for the Treatment of Gastric Cancer: A Meta-Analysis. Scientific Reports 2015; 5(1) doi: 10.1038/srep12538
|
35 |
Daniele Marrelli, Karol Polom, Giovanni de Manzoni, Paolo Morgagni, Gian Luca Baiocchi, Franco Roviello. Multimodal treatment of gastric cancer in the west: Where are we going?. World Journal of Gastroenterology 2015; 21(26): 7954-7969 doi: 10.3748/wjg.v21.i26.7954
|
36 |
Nicolas Golse, Naoual Bakrin, Guillaume Passot, Faheez Mohamed, Delphine Vaudoyer, François‐Nöel Gilly, Olivier Glehen, Eddy Cotte. Iterative procedures combining cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal recurrence: Postoperative and long‐term results. Journal of Surgical Oncology 2012; 106(2): 197 doi: 10.1002/jso.23062
|
37 |
Olivier Glehen, Guillaume Passot, Laurent Villeneuve, Delphine Vaudoyer, Sylvie Bin-Dorel, Gilles Boschetti, Eric Piaton, Alfredo Garofalo. GASTRICHIP: D2 resection and hyperthermic intraperitoneal chemotherapy in locally advanced gastric carcinoma: a randomized and multicenter phase III study. BMC Cancer 2014; 14(1) doi: 10.1186/1471-2407-14-183
|
38 |
Louis de Mestier, Sophie Lardière-Deguelte, Julien Volet, Reza Kianmanesh, Olivier Bouché. Recent insights in the therapeutic management of patients with gastric cancer. Digestive and Liver Disease 2016; 48(9): 984 doi: 10.1016/j.dld.2016.04.010
|
39 |
H. J. F. Brenkman, M. Päeva, R. van Hillegersberg, J. P. Ruurda, N. Haj Mohammad. Prophylactic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer—A Systematic Review. Journal of Clinical Medicine 2019; 8(10): 1685 doi: 10.3390/jcm8101685
|
40 |
Maneesh Kumarsing Beeharry, Zheng-Lun Zhu, Wen-Tao Liu, Xue-Xin Yao, Min Yan, Zheng-Gang Zhu. Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-6125-z
|
41 |
Jingxu Sun, Yongxi Song, Zhenning Wang, Peng Gao, Xiaowan Chen, Yingying Xu, Jiwang Liang, Huimian Xu. Benefits of hyperthermic intraperitoneal chemotherapy for patients with serosal invasion in gastric cancer: a meta-analysis of the randomized controlled trials. BMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-526
|
42 |
F. Roviello, S. Caruso, A. Neri, D. Marrelli. Treatment and prevention of peritoneal carcinomatosis from gastric cancer by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Overview and rationale. European Journal of Surgical Oncology (EJSO) 2013; 39(12): 1309 doi: 10.1016/j.ejso.2013.10.010
|
43 |
P. H. Sugarbaker. Adjuvant Intraperitoneal Chemotherapy for Advanced Primary Gastric Cancer. Scandinavian Journal of Surgery 2006; 95(4): 270 doi: 10.1177/145749690609500410
|
44 |
Satoshi Murata, Hiroshi Yamamoto, Hiroyuki Naitoh, Tsuyoshi Yamaguchi, Sachiko Kaida, Tomoharu Shimizu, Hisanori Shiomi, Shigeyuki Naka, Tohru Tani, Masaji Tani. Feasibility and safety of hyperthermic intraperitoneal chemotherapy using 5‐fluorouracil combined with cisplatin and mitomycin C in patients undergoing gastrectomy for advanced gastric cancer. Journal of Surgical Oncology 2017; 116(8): 1159 doi: 10.1002/jso.24771
|
45 |
Ye Rim Chang, Dong Seok Han, Seong-Ho Kong, Hyuk-Joon Lee, Se Hyung Kim, Woo Ho Kim, Han-Kwang Yang. The Value of Palliative Gastrectomy in Gastric Cancer with Distant Metastasis. Annals of Surgical Oncology 2012; 19(4): 1231 doi: 10.1245/s10434-011-2056-x
|
46 |
Paul H. Sugarbaker. Prevention and Treatment of Peritoneal Metastases: a Comprehensive Review. Indian Journal of Surgical Oncology 2019; 10(1): 3 doi: 10.1007/s13193-018-0856-1
|
47 |
|
48 |
Javier Sastre, Jose Angel García-Saenz, Eduardo Díaz-Rubio. Chemotherapy for gastric cancer. World Journal of Gastroenterology 2006; 12(2): 204-213 doi: 10.3748/wjg.v12.i2.204
|
49 |
Roman Yarema. Gastric cancer with high risk of intraperitoneal progression: clinical course and current treatments. Current Issues in Pharmacy and Medical Sciences 2017; 30(4): 190 doi: 10.1515/cipms-2017-0036
|
50 |
Jun Yamada, Joji Kitayama, Nelson H. Tsuno, Hiroharu Yamashita, Hideyo Miyato, Daisuke Soma, Kensuke Otani, Takao Kamei, Hironori Ishigami, Akio Hidemura, Shoichi Kaisaki, Koki Takahashi, Hirokazu Nagawa. Intra-peritoneal administration of paclitaxel with non-animal stabilized hyaluronic acid as a vehicle – A new strategy against peritoneal dissemination of gastric cancer. Cancer Letters 2008; 272(2): 307 doi: 10.1016/j.canlet.2008.07.024
|
51 |
Franco Roviello, Tommaso Cioppa, Daniele Marrelli, Stefano Caruso, Enrico Pinto. Treatment of Peritoneal Surface Malignancies. Updates in Surgery 2015; : 255 doi: 10.1007/978-88-470-5711-1_18
|
52 |
F. Coccolini, E. Cotte, O. Glehen, M. Lotti, E. Poiasina, F. Catena, Y. Yonemura, L. Ansaloni. Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials. European Journal of Surgical Oncology (EJSO) 2014; 40(1): 12 doi: 10.1016/j.ejso.2013.10.019
|
53 |
Beatrice Mohelníková-Duchoňová, Radmila Lemstrová, Dušan Klos, Jan Hanuliak, Martin Stašek, Čestmír Neoral, Bohuslav Melichar. Significance of systemic chemotherapy and hyperthermic intraperitoneal chemotherapy in primary and secondary peritoneal surface malignancies. Onkologie 2017; 11(6): 289 doi: 10.36290/xon.2017.053
|
54 |
Thorsten O. Götze, Pompiliu Piso, Sylvie Lorenzen, Ulli S. Bankstahl, Claudia Pauligk, Moustafa Elshafei, Giuseppe Amato, Daniel Reim, Wolf O. Bechstein, Alfred Königsrainer, Stefan P. Mönig, Beate Rau, Matthias Schwarzbach, Salah-Eddin Al-Batran. Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08872-8
|
55 |
Hamza Khan, Fabian M. Johnston. Current role for cytoreduction and HIPEC for gastric cancer with peritoneal disease. Journal of Surgical Oncology 2022; 125(7): 1176 doi: 10.1002/jso.26894
|
56 |
Lung-Yun Kang, King-Tong Mok, Shiuh-Inn Liu, Cheng-Chong Tsai, Being-Whey Wang, I-Shu Chen, Yu-Chia Chen, Bo-Min Chang, Nan-Hua Chou. Intraoperative hyperthermic intraperitoneal chemotherapy as adjuvant chemotherapy for advanced gastric cancer patients with serosal invasion. Journal of the Chinese Medical Association 2013; 76(8): 425 doi: 10.1016/j.jcma.2013.04.004
|
57 |
Maneesh Kumarsing Beeharry, Zhen-Tian Ni, Zhong Yin Yang, Ya Nan Zheng, Run Hua Feng, Wen-Tao Liu, Chao Yan, Xue Xin Yao, Chen Li, Min Yan, Zheng-Gang Zhu. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-6701-2
|
58 |
Evangelos Briasoulis, Theodore Liakakos, Lefkothea Dova, Michael Fatouros, Pericles Tsekeris, Dimitrios H Roukos, Angelos M Kappas. Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer. Expert Review of Anticancer Therapy 2006; 6(6): 931 doi: 10.1586/14737140.6.6.931
|
59 |
F. Bozzetti, W. Yu, Dario Baratti, Shigeki Kusamura, Marcello Deraco. Locoregional treatment of peritoneal carcinomatosis from gastric cancer. Journal of Surgical Oncology 2008; 98(4): 273 doi: 10.1002/jso.21052
|
60 |
Tristan D Yan, Oswald A Stuart, Dal Yoo, Paul H Sugarbaker. Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy. Journal of Translational Medicine 2006; 4(1) doi: 10.1186/1479-5876-4-17
|
61 |
M. Yu Reutovich, O.V. Krasko, O.G. Sukonko. Hyperthermic intraperitoneal chemotherapy in serosa-invasive gastric cancer patients. European Journal of Surgical Oncology 2019; 45(12): 2405 doi: 10.1016/j.ejso.2019.07.030
|
62 |
SHENG-LIU XUE, HUA-FANG SU, XIAO-QU HU, XIA DENG, MEI-LONG HU, CONG-YING XIE. Adjuvant combined systemic chemotherapy and intraperitoneal chemotherapy for locally advanced gastric cancer. Oncology Letters 2012; 4(6): 1309 doi: 10.3892/ol.2012.914
|
63 |
P M Schlag. Authors' reply: Surgical strategies for gastric cancer with synchronous peritoneal carcinomatosis (Br J Surg 2006; 93: 1530–1535). British Journal of Surgery 2007; 94(5): 642 doi: 10.1002/bjs.5868
|
64 |
Zheng He, Ting-Ting Zhao, Hui-Mian Xu, Zhen-Ning Wang, Ying-Ying Xu, Yong-Xi Song, Zhong-Ran Ni, Hao Xu, Song-Cheng Yin, Xing-Yu Liu, Zhi-Feng Miao. Efficacy and safety of intraperitoneal chemotherapy in patients with advanced gastric cancer: a cumulative meta-analysis of randomized controlled trials. Oncotarget 2017; 8(46): 81125 doi: 10.18632/oncotarget.20818
|
65 |
Tristan D. Yan, Deborah Black, Paul H. Sugarbaker, Jacqui Zhu, Yutaka Yonemura, George Petrou, David L. Morris. A Systematic Review and Meta-analysis of the Randomized Controlled Trials on Adjuvant Intraperitoneal Chemotherapy for Resectable Gastric Cancer. Annals of Surgical Oncology 2007; 14(10): 2702 doi: 10.1245/s10434-007-9487-4
|